Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AGN-229666 in Japanese patients with allergic conjunctivitis
NCT01754766Phase 2Completed
- Sponsor
- Allergan
- Start
- Oct 2012
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of alcaftadine in allergic conjunctivitis (AC), sponsored by Allergan. Started Oct 2012; status: completed.
02
Drugs
alcaftadine
03
Conditions
allergic conjunctivitis (AC)
Beyond the preview
Go deeper on NCT01754766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01754766.